Date lodged: 21 June 2017
To ask the Scottish Government how it will ensure that all diabetes patients who would benefit from continuous glucose monitoring are able to access this technology.
Answered by: Aileen Campbell 29 June 2017
There is now a well-established evidence base for the benefits of Continuous Glucose Monitoring (CGM) as an aid to improve glycaemic control for a small number of people with Type 1 diabetes.
We have worked with the Scottish Diabetes Group (SDG) to develop an National Approach to support the uptake and increased provision of Continuous Glucose Monitoring (CGM).